It can target TGFBR1 mRNA 3′UTR and repress its expression, thus abrogating the TGF-β signal and eventually increasing DDP chemosensitivity in NSCLC cells [136]. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.